Literature DB >> 8992981

CD28 costimulation promotes the production of Th2 cytokines.

I C Rulifson1, A I Sperling, P E Fields, F W Fitch, J A Bluestone.   

Abstract

CD28 ligation augments TCR-mediated proliferation, IL-2 production, and T cell survival. However, the role of CD28 costimulation in T cell differentiation remains controversial. To address this issue, CD28+ and CD28-deficient TCR alphabeta transgenic (Tg) mice were used to examine cytokine production by T cells following antigenic stimulation. Increasing CD28 ligation resulted in increased production of IL-4 and IL-5, consistent with differentiation toward a Th2 phenotype, in both CD4+ TCR Tg T cells and CD8+ TCR Tg T cells. The same result was obtained with CD4+ TCR Tg mice bred to RAG2-deficient mice, indicating that the Th2 differentiation observed with increased CD28 ligation was not due to the presence of memory T cells. Although CD28 costimulation is an essential factor regulating IL-2 synthesis, differentiation toward a Th2-like phenotype by CD28 ligation was not an indirect effect of enhanced IL-2 production. In contrast, blockade of IL-4 during the primary cultures of the T cells resulted in a profound inability to produce Th2-type cytokines upon restimulation. The critical role of IL-4 was confirmed by the finding that CD28-deficient TCR alphabeta Tg+ T cells cultured with rIL-4 differentiated into Th2-like T cells. Therefore, CD28 ligation promotes the production of Th2-type cytokines by naive murine T cells via an IL-4-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8992981

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  65 in total

1.  B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.

Authors:  D A Mandelbrot; M A Oosterwegel; K Shimizu; A Yamada; G J Freeman; R N Mitchell; M H Sayegh; A H Sharpe
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 2.  Controlling mature CD4+ T cell responses.

Authors:  M E Ozaki; S R Webb
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 3.  Educating T cells: early events in the differentiation and commitment of cytokine-producing CD4+ and CD8+ T cells.

Authors:  A Kelso
Journal:  Springer Semin Immunopathol       Date:  1999

Review 4.  CD28, CTLA-4 and their ligands: who does what and to whom?

Authors:  D M Sansom
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

5.  Active Crohn's disease patients show a distinctive expansion of circulating memory CD4+CD45RO+CD28null T cells.

Authors:  Jaime García de Tena; Luis Manzano; Juan Carlos Leal; Esther San Antonio; Verónica Sualdea; Melchor Alvarez-Mon
Journal:  J Clin Immunol       Date:  2004-03       Impact factor: 8.317

Review 6.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

7.  CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.

Authors:  P Nair; R Melarkode; D Rajkumar; E Montero
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

8.  Naive human T cells can be a source of IL-4 during primary immune responses.

Authors:  D M Bullens; K Rafiq; A Kasran; S W Van Gool; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

9.  CD28-mediated costimulation impacts on the differentiation of DC vaccination-induced T cell responses.

Authors:  H Voigt; D Schrama; A O Eggert; C S Vetter; K Müller-Blech; H M Reichardt; M H Andersen; J C Becker; F Lühder
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

10.  CD28-B7 interaction modulates short- and long-lived plasma cell function.

Authors:  Modesta N Njau; Jin Hyang Kim; Craig P Chappell; Rajesh Ravindran; Leela Thomas; Bali Pulendran; Joshy Jacob
Journal:  J Immunol       Date:  2012-08-20       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.